| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 111689-01-1 | b-Cyclodextrin,2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G,6A,6B,6C,6D,6E,6F,6G-heneicosa-O-ethyl-; 2,4,7,9,12,14,17,19,22,24,27,29,32,34-Tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane,b-cyclodextrin deriv.; Hepta-(2,3,6-tri-oxy-ethyl)-b-cyclodextrin; Heptakis(2,3,6-tri-O-ethyl)-b-cyclodextrin; Perethylated b-cyclodextrin | ![]() | C84H154O35 | 详情 | 供应商 | |
| 23666-43-5 | b-Cyclodextrin,2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G,6A,6B,6C,6D,6E,6F,6G-heneicosabenzoate; b-Cyclodextrin, heneicosabenzoate(8CI,9CI); 2,4,7,9,12,14,17,19,22,24,27,29,32,34-Tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane,b-cyclodextrin deriv.; Hepta-(2,3,6-tri-oxy-benzoyl)-b-cyclodextrin; Heptakis(2,3,6-tri-O-benzoyl)-b-cyclodextrin; b-Cyclodextrin perbenzoate | ![]() | C189H154O56 | 详情 | 供应商 | |
| 25759-28-8 | Insulin (cod-A reduced)(8CI,9CI); Insulin(ox-A reduced), 4-L-aspartic acid-8-L-histidine-9-L-arginine-10-L-proline-12-L-asparticacid-13-L-isoleucine-14-L-phenylalanine-15-L-aspartic acid-17-L-glutamine-; L-Asparagine, glycyl-L-isoleucyl-L-valyl-L-a-aspartyl-L-glutaminyl-L-cysteinyl-L-cysteinyl-L-histidyl-L-arginyl-L-prolyl-L-cysteinyl-L-a-aspartyl-L-isoleucyl-L-phenylalanyl-L-a-aspartyl-L-leucyl-L-glutaminyl-L-asparaginyl-L-tyrosyl-L-cysteinyl- | ![]() | C102H154N30O33S4 | 详情 | 供应商 | |
| 85916-47-8 | Katacalcin (human)(9CI); 108: PN:US20050009742 SEQID: 8 unclaimed sequence; 181: PN: US20090175821 SEQID: 222claimed protein; 43: PN: WO0069900 SEQID: 222 unclaimed sequence; Calcitonincarboxy-terminal flanking peptide (human); Human carboxy terminalcalcitonin-adjacent peptide; L-Asparagine, L-a-aspartyl-L-methionyl-L-seryl-L-seryl-L-a-aspartyl-L-leucyl-L-a-glutamyl-L-arginyl-L-a-aspartyl-L-histidyl-L-arginyl-L-prolyl-L-histidyl-L-valyl-L-seryl-L-methionyl-L-prolyl-L-glutaminyl-L-asparaginyl-L-alanyl-; PDN 21 | ![]() | C97H154N34O36S2 | 详情 | 供应商 | |
| 159650-20-1 | Sarafotoxin a 1 (9CI); L-Tryptophan,L-cysteinyl-L-seryl-L-cysteinyl-L-lysyl-L-a-aspartyl-L-methionyl-L-seryl-L-a-aspartyl-L-lysyl-L-a-glutamyl-L-cysteinyl-L-leucyl-L-asparaginyl-L-phenylalanyl-L-cysteinyl-L-histidyl-L-glutaminyl-L-a-aspartyl-L-valyl-L-isoleucyl-,cyclic (1® 15),(3® 11)-bis(disulfide) | ![]() | C104H154N28O34S5 | 详情 | 供应商 | |
| 908012-18-0 | ZIP (SCRAMBLED) | ![]() | C90H154N30O17 | 详情 | 供应商 | |
| 108341-22-6 | MANNOTRIOSE-(FUCOSYL-DI-[N-ACETYLGLUCOSAMINE]), BIS(SIALYL-GALACTOSYL-N-ACETYLGLUCOSAMINYL)-AMMONIUM; MANNOTRIOSE-(FUCOSYL-DI-[N-ACETYLGLUCOSAMINE]), BIS(SIALYL-GALACTOSYL-N-ACETYLGLUCOSAMINYL)-AMMONIUM SALT; [NEUNAC-GAL-GLCNAC]2MAN3[FUC][GLCNAC]2 AMMONIUM SALT; mannotriose-(fucosyl-di-(N-acetyl-*glucosamine)),; (neunac-gal-glcnac)2man3(fuc)(glcnac)2; a2f glycan ammonium salt from porcine thyroglobulin; A2F Glycan ammonium salt; Disialylated, galactosylated, fucosylated biantennary N-linked glycan, Mannotriose-(fucosyl-di-[N-acetylglucosamine]), bi(sialyl-galactosyl-N-acetylglucosaminyl), (NeuNAc-Gal-GlcNAc)2Man3(Fuc)(GlcNAc)2; Disialylated, galactosylated, fucosylated biantennary glycan (A2F) | ![]() | C90H154N8O66 | 详情 | 供应商 |